FABP4 and type 2 diabetes mellitus: Circulating FABP4 levels exhibit a strong positive correlation with diabetes and cardiovascular disease, and multiple independent genome-wide association studies have identified protection in individuals with a low-expression variant of FABP4 against type 2 diabetes and cardiovascular diseases (34, 35, 36).